Submission

Refine

  • Submission

    The MHCA applauds the Safety and Quality Partnership Subcommittee’s recognition of the role of recovery as critical to better mental health services and encourages an organisational learning approach and the establishment of a national strategy.

  • Submission

    In this submission the MHCA congratulates the Mental Health Standing Committee for its recognition of the role of recovery as critical to the implementation of better mental health services, and makes a series of suggestions context of our desire to drive lasting change in the delivery of recovery based services to mental health consumers and carers. These suggestions centre around ensuring a focus on people with lived experience and maximising the impact of the Framework through a range of educational and sector development mechanisms.

  • Submission

    In this submission the MHCA reiterates the outcomes of its consultations with consumer and carer representatives, which the Council does not believe were reflected in the subsequent Draft Roadmap. In particular, the MHCA found that the Draft Roadmap does not make reference to any specific goals, targets, funding commitments or specific measurements that would indicate what the Australian mental health system will look in 10 years time, and how it will make progress from where it is now.

  • Submission

    Medicines play an important part in the maintenance and treatment of mental illness and the MHCA has a keen interest in the governance structures which oversee the conduct of the Australian innovative pharmaceutical sector. In this submission the MHCA promotes consumer and carer engagement as effective strategies to include in the Medicines Australia Code of Conduct.

  • Submission

    This submission highlights the specific challenges faced by people with experience of mental illness in applying for, or making claims against insurance policies, in particular those where they relate to the private health insurance sector.

  • Submission

    The MHCA focus for this submission is on Cabinet’s proposal to become the decision-making body for approving all Pharmaceutical Benefits Scheme listings. The MHCA makes a number of recommendations to ensure that a high level of equity, accountability and transparency is maintained in Pharmaceutical Benefits Advisory Committee processes.

  • Submission

    The MHCA supports the development of a social insurance scheme for disability long-term care and support, but is concerned about the lack of understanding revealed during the inquiry about the urgent need for disability support for people with a mental illness.

  • Submission

    The MHCA strongly supports the development of a social insurance scheme for disability long term care and support in Australia and congratulates the Productivity Commission and the Department of Families, Housing, Community Services and Indigenous Affairs for tackling such an important and timely task. Effective long term disability support is necessary to meet Australia’s obligations under the United Nation’s Convention on Rights for Persons with a Disability and, most importantly, to rectify the grave and unnecessary injustices faced daily by people with a disability in Australia.

  • Submission

    This paper summarises the commitments made by governments on the investment in sub-acute care, the evidence to support various models of sub-acute care and the key issues relating to these commitments in relation to the Australian mental health sector.

  • Submission

    This paper summarises the positions taken by the MHCA and its members in relation to the proposed National Health and Hospitals Network reforms in relation to the mental health sector. These issues are proposed to underpin a whole of sector advocacy position.

Pages

Subscribe to RSS - Submission

© 2024 Mental Health Australia All rights reserved.